What CSO Pharma Consulting GmbH does

CSO Pharma Consulting GmbH is a privately held German professional consulting firm headquartered in Munich, founded in 2010 by Dr. Silke Ostermann MBA. The company delivers specialized regulatory and compliance services to pharmaceutical companies, biotech firms, wholesale distributors, and healthcare organizations across the DACH region and internationally. Its service portfolio is organized around three pillars: Compliance, Safety, and Organisation Development, encompassing pharmacovigilance (ICSR processing, PSMF preparation, QPPV and Stufenplanbeauftragter outsourcing, signal detection, PSUR/PBRER/DSUR preparation, risk management plans, PV audits, inspection readiness), medical affairs (24/7 medical hotline, medical information management, labeling and HWG compliance, xEVMPD/ISO-IDMP data entry, socialvigilance, accessible patient leaflets), quality management and GxP consulting (SOP development, audit support, serialization), GDP and wholesale license support (Großhandelserlaubnis acquisition and responsible person outsourcing), regulatory compliance, and public/private training programs delivered through partners including Forum Institut, LS Academy, and TÜV SÜD/BioM.

The underlying technology stack is minimal: CSO Pharma operates as a human-expert-delivered consulting business with no proprietary AI/ML platform or algorithm disclosed. The principal technical artifact is a password-protected ICSR-Online Portal providing document-level access control, audit trail, version control, and automated reminder functions for case safety report management. Services are delivered by a multicultural team of scientists, pharmacists, physicians, and economists qualified to assume legally mandated responsible-person roles under EU and German pharmaceutical law.

The business model is fee-for-service professional consulting on a project or retainer basis, with quote-based engagement pricing that is not publicly disclosed. Revenue is generated across operative outsourced functions (QPPV, GPO, Responsible Person for Wholesale), strategic advisory, process implementation, training delivery, and ongoing service contracts. Go-to-market relies on direct B2B outreach to regulatory, pharmacovigilance, quality, and medical affairs decision-makers, complemented by industry working group participation (MEGRA, ECA Foundation GDP-Group, Munich PV Working Group), public training programs, and inclusion in the athagoras group of healthcare service providers. The company maintains a 1-10 employee footprint with no disclosed external funding, operating as a founder-led boutique practice.

Name

CSO Pharma Consulting GmbH

Legal name

CSO Pharma Consulting GmbH

Website

https://cso-pharma.eu

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

CSO Pharma Consulting GmbH is a Munich-based pharma consulting firm founded in 2010, delivering pharmacovigilance, medical affairs, quality management, GDP, and regulatory compliance services to pharmaceutical companies, biotech firms, and wholesale distributors across Germany and internationally.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory & Pharmacovigilance Consulting

NAICS

Other Management Consulting Services (541618), Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Pharmacovigilance consulting
• Medical affairs services
• Pharmaceutical quality management
• GDP wholesale licensing
• Regulatory compliance consulting

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Professional Consulting Services: CSO Pharma generates revenue through fee-for-service consulting engagements across pharmacovigilance, medical affairs, quality management, GDP, and regulatory compliance. Services are tailored to client needs and delivered as project-based or retainer engagements. Revenue is derived from operative support, strategic consulting, process implementation, training delivery, and outsourced functional responsibilities (e.g., acting as QPPV, GPO, or Responsible Person for Wholesale).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

CSO Pharma Consulting GmbH provides fee-based professional consulting and outsourced operational services to pharmaceutical, biotech, and healthcare organizations in three core areas: Compliance (pharmacovigilance, medical affairs, quality management, GDP / wholesale licensing, regulatory compliance) and Organisation Development (process design and implementation support). Services span ICSR processing, PSMF implementation, QPPV and Stufenplanbeauftragter outsourcing, 24/7 medical enquiry hotlines, SOP development, audit support, serialization, training, and acting as Responsible Person for Wholesale. Engagements are delivered as project-based or retainer outsourced mandates rather than as discrete software products.

Product overview

CSO Pharma Consulting GmbH is a German consulting and service company founded by Dr. Silke Ostermann MBA in 2010, offering a comprehensive portfolio of professional services for pharmaceutical companies and healthcare organizations. The company operates as a single unified service offering organized around three core pillars: Compliance, Safety, and Organisation Development. The core services include Pharmakovigilance (PV) Services covering the complete portfolio from ICSR processing to full PV system implementation and QPPV responsibilities; Medical Affairs Services providing medical hotline, product information management, labeling compliance, and information officer functions; Quality Management/GxP Services for system development, SOP creation, and audit support; Regulatory Compliance for life cycle management and variation submissions; GDP/Wholesale License Support for distribution practice compliance; and Training Services for pharmacovigilance, quality management, and process implementation. The company also provides specialized sub-services including PV audits, socialvigilance, serialization support, contract services, and an ICSR-Online portal. CSO Pharma serves pharmaceutical products, medical devices, and supplements, and operates as part of the athagoras group of leading service providers.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmakovigilance Services Complete portfolio of pharmacovigilance services including ICSR processing, PV system implementation, PSMF preparation, signal detection, literature screening, PSUR/PBRER/DSUR reports, risk management plans, QPPV services, and regulatory inspection readiness support for pharmaceutical companies and marketing authorization holders.
• Medical Affairs Services Medical information and hotline services including 24/7 enquiry handling, medical writing, product information management, labeling compliance, advertising law (HWG) compliance assessment, and information officer responsibilities for pharmaceutical companies.
• Quality Management (QM) / GxP Services Quality management system development, SOP creation, audit support, self-inspection services, process optimization, and integration with GxP standards (GDP, GMP, GVP, GCP, GLP, ISO) for pharmaceutical and healthcare organizations.
• Regulatory Compliance / Regulatory Affairs Life cycle management including classification and submission of variations, WHO certificates, CoPPs, PSUR submissions, risk management plan updates, deficiency letter responses, and product information text reviews for pharmaceutical companies.
• GDP / Wholesale License Support Good Distribution Practice implementation, wholesale license (Großhandelserlaubnis) obtainment support, GDP responsible person services, supplier and customer qualification, and GDP audit support for pharmaceutical wholesale distributors.
• Training Services Hands-on training programs covering pharmacovigilance, quality management, GxP standards, process development, and change management with practice-oriented workshops and interactive sessions for pharmaceutical industry professionals.
• Organisation Development Strategic organisational consulting to help pharmaceutical companies establish compliant and efficient processes, including process analysis, implementation support, and continuous improvement.
• Audit and Inspection Readiness Services Pharmacovigilance audit services, shared audits, internal self-inspection support, regulatory inspection readiness preparation, documentation preparation, mock audits, and corrective action implementation for pharmaceutical companies.
• ICSR-Online Portal Service Password-protected 24/7 online portal for individual case safety report management with document-level access control, audit trail, version control, and automated reminder functions, delivered as part of CSO Pharma's pharmacovigilance service.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core, moderate and minor.

• athagoras groupcoreStrategic or Co-development PartnerCSO Pharma is part of the athagoras group, a group of leading service providers united in supporting pharma, biotech, and healthcare companies to achieve fast and efficient market access for their products. The group addresses challenges including increasing competition, pricing pressure, volatile supply chains, and regulatory pressure. CSO Pharma contributes its expertise in compliance, safety, and organization development within the group structure, enabling the group to offer a broader suite of integrated healthcare services.
• MEGRA (Mitteleuropäische Gesellschaft für Regulatory Affairs)coreOthersMEGRA is the Middle European Association for Regulatory Affairs. CSO Pharma is a member and participates in MEGRA Training Committee activities. MEGRA organizes regular training events on current topics such as pharmacovigilance audits and quality defects, providing CSO Pharma with access to industry knowledge, networking, and thought leadership opportunities.
• GDP-Group (Interest Group of the ECA Foundation)moderateOthersThe GDP-Group is an interest group of the ECA Foundation focused on Good Distribution Practice. Membership enables CSO Pharma to stay current with GDP regulatory developments, participate in GDP audits guidance initiatives, and network with other GDP professionals.
• Pharmakovigilanz Arbeitskreis MünchenmoderateOthersThe Munich Pharmacovigilance Working Group is a professional network for PV practitioners in the Munich region. Membership supports knowledge exchange and professional development in pharmacovigilance.
• PV Audit Group (LinkedIn)minorOthersA LinkedIn-based professional network for pharmacovigilance audit practitioners. CSO Pharma participates to exchange audit practices, regulatory developments, and benchmarking information with peers.
• GDP Gruppe (XING)minorOthersA XING-based professional network focused on Good Distribution Practice. CSO Pharma participates in this group for GDP knowledge exchange and professional networking within the German-speaking pharmaceutical distribution community.
• Forum - Institut für Management GmbHmoderateGTM or Marketing PartnerCSO Pharma partners with Forum Institut to deliver GVP-Auditor training courses and Pharmakovigilanz Compliance seminars. CSO Pharma personnel serve as instructors for these public training programs, generating leads while building thought leadership in the pharmacovigilance auditing space.
• LS AcademyminorGTM or Marketing PartnerCSO Pharma collaborates with LS Academy to deliver training programs on Risk Management Plans and PSMF (Pharmacovigilance System Master File) creation and implementation. The partnership extends CSO Pharma's reach in the training market.
• TÜV SÜD Akademie / BioMminorGTM or Marketing PartnerCSO Pharma participates in the TÜV SÜD (in collaboration with BioM) modular training program 'Manager Klinische Entwicklung Pharma & Biotechnologie' held annually in Munich and Frankfurt. This engagement positions CSO Pharma within the biotech education ecosystem.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Global CRO and life sciences services giant offering pharmacovigilance, regulatory, quality, and consulting across the full pharma value chain. Serves as a broader incumbent against which CSO Pharma competes on specialized EU/German compliance depth.

Direct peers

• Voisin Consulting Life Sciences (VCLS): Life sciences regulatory and pharmacovigilance consultancy with deep EU expertise, serving pharma and biotech across regulatory strategy, clinical, and post-marketing safety — directly overlaps CSO Pharma's core PV and regulatory services.
• Remap Consulting: Pharmaceutical regulatory affairs and development consultancy providing EU regulatory strategy, submissions, and lifecycle support — comparable to CSO Pharma's regulatory affairs service line.
• QbD Group: Pharma and biotech quality and compliance consultancy specializing in GMP, validation, and regulatory support. Comparable boutique-mid consulting model focused on GxP services to life sciences clients.
• Arriello: Regulatory affairs, pharmacovigilance, and compliance consulting firm for pharma and biotech, with a focus on EU frameworks. Similar boutique-mid profile with overlapping PV, regulatory, and quality service lines.
• Maetrics: Life sciences quality, compliance, and regulatory consulting firm offering GxP, validation, and quality management services to pharma and medical device manufacturers — directly comparable in QM/GxP scope.
• Diamond Pharma Services: UK-based pharma regulatory affairs, pharmacovigilance, and quality consultancy supporting MAHs and biotech — overlaps CSO Pharma's PV and regulatory lifecycle services, though with a UK rather than German base.
• PharmaLex (now part of GBA Group): Directly comparable pharma regulatory affairs, pharmacovigilance, and quality management consulting firm serving MAHs and biotech. Operates with a similar service portfolio (PV, QPPV, regulatory, QM) across multiple geographies, but at significantly greater scale.
• ProPharma Group: Specialist GxP compliance, pharmacovigilance, and regulatory consulting firm serving pharma, biotech, and medical device companies. Closely comparable service offering including PV, quality, and regulatory affairs consulting.

Emerging players

• NNIT Life Sciences: IT and consulting services provider to life sciences, with GxP, regulatory, and digital compliance offerings. Adjacent but growing overlap with CSO Pharma's regulatory and quality management consulting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cso-pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CSO Pharma Consulting GmbH